![](/img/cover-not-exists.png)
99 NOVEL FXR AGONISTS WITH POTENT LIPID LOWERING, INSULIN SENSITISING, ANTI-INFLAMMATORY AND ANTI-FIBROTISATION EFFECTS IN MOUSE MODELS OF METABOLIC SYNDROME AND NASH
C. Kremoser, E. Hambruch, U. Deuschle, O. Kinzel, M. Burnet, H. YoneyamaVolume:
54
Year:
2011
Language:
english
DOI:
10.1016/s0168-8278(11)60101-3
File:
PDF, 32 KB
english, 2011